Evaluation of Mpox Exposures and Outcomes in Workplaces, 6 Jurisdictions, June 1-August 31, 2022.
Marie A de PerioLibby HorterWilliam StillIe MehNancy PerssonAbby L BernsAndrea SalinasKatherine MurphyAllison G LaffertyDaniel DaltrySkyler MackeyDenise C SockwellJeremy AdamsJenniffer RivasNicholas J SomervilleDiana ValenciaPublished in: Public health reports (Washington, D.C. : 1974) (2024)
Data from 6 jurisdictions suggest that the risk of MPXV transmission from workers to others in workplace settings in many industries is low. These findings might support future updates to exposure risk classifications and work activity recommendations for patients. These findings also demonstrate the importance of collecting and analyzing occupation and industry data in case reports to better understand risks in workplaces.